Schedule 13G ownership disclosure

PTC Therapeutics Inc

Common Stock · CUSIP: 69366J200

Event date: 2025-09-30

Filing-level shares
8,288,999
Percent of class
10.43%
  • The Vanguard Group

    Shares: 8,288,999 · Class: 10.43%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-25-000196
Form type
SCHEDULE 13G/A
Filer
PTC THERAPEUTICS, INC.
CIK
CIK 1070081
Filed
Oct 30, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub